Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lumiera Health Inc V.NHP.H

Lumiera Health Inc. is a Canadian company that specializes in the development and commercialization of natural health products. Its brands consist of Holizen Laboratories, Awaye pain relief cream, and Bazzzics. Through its Holizen Laboratories division, the Company sells both oral and topical formulations to help manage a range of therapeutic needs, including a new generation of natural sleep... see more

Recent & Breaking News (TSXV:NHP.H)

Lumiera Health expands online distribution with Bazzzics(TM) sleep-aids on Amazon and Well.ca

Canada NewsWire March 31, 2022

Lumiera Health Inc. (TSXV:NHP) signs distribution agreement with Fideschem International Ltd.

John Ballem  March 25, 2022

Lumiera Health signs distribution agreement to launch Awaye(TM) in Vietnam - a market of 100 million people

Canada NewsWire March 24, 2022

Lumiera begins fiscal year strong with +25% growth in Q1 2022 compared to previous year

Canada NewsWire March 22, 2022

Lumiera Health signs definitive agreement to launch Awaye(TM) in the US and receives NDC from FDA

Canada NewsWire March 8, 2022

Lumiera Health changes their debt structure to allocate more cash for accelerated growth

Canada NewsWire February 25, 2022

As part of US expansion plans Lumiera Health Appoints Jacqueline Khayat to Board of Directors

PR Newswire February 22, 2022

Lumiera Health signs binding term sheet to launch Awaye(TM) pain relief cream in the US

PR Newswire February 15, 2022

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

Accesswire December 2, 2021

Lumiera (TSXV:NHP) ends fiscal year on a high note with strong sales in November

John Ballem  December 2, 2021

Lumiera ends fiscal year strong with sales in November 2021 up 59% compared to November 2020

PR Newswire December 2, 2021

Lumiera Health Appoints Louis Doyle to Board of Directors

PR Newswire November 18, 2021

The StockTalk Cannabis Report: Nov 12, 2021

Dave Jackson November 12, 2021

Changing the Health and Wellness Space Through Endocannabinoid-based Products

Jocelyn Aspa November 9, 2021

Lumiera's new first of its kind pain relief cream, Awaye(TM), activates the body's cannabinoid type 2 receptors to decrease pain and inflammation.

PR Newswire October 19, 2021

Lumiera Health announces launch of its new Direct-to-Consumer platform

PR Newswire October 8, 2021

Lumiera Health announces Private Placement Extension

PR Newswire September 14, 2021

Lumiera Health begins sales of Awaye(TM) pain relief cream on Amazon marketplace

PR Newswire August 20, 2021

Lumiera Health announces proposed $900,000 Private Placement

PR Newswire August 6, 2021

Lumiera Health announces closing of $1.3 Million private placement

PR Newswire July 12, 2021